The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 162.00
Ask: 162.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.309%)
Open: 162.00
High: 162.50
Low: 162.00
Prev. Close: 162.00
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Confirmation of Interim Dividend

1 Oct 2020 07:00

RNS Number : 6721A
TClarke PLC
01 October 2020
 

TClarke plc

 Trading Update and confirmation of Interim Dividend Payment

TClarke plc, the Building Services Group, today issues a Trading Update covering the period from 30th June 2020 to date and announces that the Board is proposing an interim dividend.

 

2020 Trading Update

 

TClarke has continued to deliver an encouraging trading performance; all of our sites are now open and we are pleased with improving levels of productivity being achieved.

 

The Group has demonstrated its resilience despite the inevitable impact on the business; by taking action so quickly TClarke remains financially strong and profitable. TClarke achieved its target 3% underlying operating profit (EBIT) margin in Q1, broke even on much reduced volumes in Q2 and is pleased to report that it expects to return to 3% EBIT margin in H2.

 

As previously announced, TClarke undertook a swift restructuring programme that has resulted in savings in excess of £4m per annum, with 2020 benefitting from £2.5m of these savings. The cost of the restructuring programme is £3.6m which will be included in non underlying items in the year end accounts.

 

Dividend

 

As a result of the Board's growing confidence, an interim dividend of 0.75p per share (2019 0.75p) is being proposed. This will be paid on 13 November 2020 to shareholders on the register on 16 October 2020 (the shares will be marked ex dividend on 15 October).

 

Outlook

 

As a result of the current market conditions and activity levels, the Board is now in a position to reinstate guidance for the 2020 financial year. Accordingly, we currently anticipate turnover for 2020 to be circa £240m and underlying EBIT to be approximately £6m.

 

The strength of the business is underpinned by our forward order book which remains at a near record of £410m. Throughout the year there continues to be high levels of bidding opportunities. Assuming there are no further significant business interruptions arising from any widespread secondary lockdown the Board is cautiously optimistic for the medium term outlook and continuing to meet our 3% EBIT margin.

 

Looking beyond 2020 our proven strategy remains to focus on projects and markets that meet our margin and growth criteria. The business is resilient and is agile, being able to shift its resources and focus accordingly. The strategy we have followed has resulted in TClarke being particularly strong in the healthcare, education and data centre market sectors, whilst continuing to serve the commercial office market.

 

Once again, the Board would like to thank all the dedicated TClarke employees who have supported the business throughout this period.

 

Ends

 

"The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014."

 

Date 1st October 2020

 

For further information, contact:

 

TClarke plc

Mark Lawrence - Group Chief Executive

Trevor Mitchell - Finance Director

Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Max Hartley (Corporate Finance)

Nick Searle (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLMMFTMTBJBBM
Date   Source Headline
8th May 20243:05 pmPRNForm 8.3 - TClarke Plc
7th May 20247:00 amPRNForm 8.3 - TClarke Plc
3rd May 20241:55 pmPRNForm 8.3 - TClarke Plc
2nd May 20241:40 pmPRNForm 8.3 - TClarke Plc
2nd May 20247:00 amRNSPublication of Scheme Document and Timetable
1st May 202410:42 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 202412:16 pmRNSForm 8 (DD) - TClarke Plc
30th Apr 202412:16 pmRNSForm 8 (DD) - TClarke Plc
30th Apr 202412:16 pmRNSForm 8 (DD) - TClarke Plc
30th Apr 202412:16 pmRNSForm 8 (DD) - TClarke Plc
29th Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
29th Apr 20248:03 amRNSIssue of Equity & Total Voting Rights
26th Apr 20241:28 pmPRNForm 8.3 - TClarke Plc
26th Apr 202410:09 amRNSForm 8.5 (EPT/NON-RI) - TClarke PLC
25th Apr 20241:56 pmPRNForm 8.3 - TClarke Plc
25th Apr 202411:52 amRNSForm 8.3 - TClarke PLC
25th Apr 20249:18 amRNSForm 8 (OPD) - TClarke plc
24th Apr 20247:21 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
19th Apr 20241:21 pmPRNForm 8.3 - TClarke Plc
18th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
18th Apr 20247:00 amRNSForm 8.1: Regent Acquisitions Limited
17th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
17th Apr 20243:03 pmGNWForm 8.3 - [TCLARKE PLC - 16 04 2024] - (CGAML)
17th Apr 202412:57 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Opening Position Disclosure Re: Clarke (T.) PLC
17th Apr 20249:47 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20244:36 pmRNSWider Regent Group Interests in TClarke Shares
16th Apr 20247:00 amRNSRevised Dividend Timetable
16th Apr 20247:00 amRNSRecommended Cash Acquisition of TClarke plc
9th Apr 20241:41 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:34 pmRNSTR-1 Notification of Holdings
27th Mar 20242:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSBlock listing Interim Review
30th Nov 20237:00 amRNSTrading Update
24th Oct 202310:21 amRNSChange of Corporate Broker
27th Jul 20234:24 pmRNSTR-1: Notification of Change of Holding
24th Jul 20235:43 pmRNSUpdate on Admission
24th Jul 20233:32 pmRNSTR-1: Notification of Change of Holding
24th Jul 202311:48 amRNSResult of GM & Total Voting Rights
13th Jul 20231:23 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHalf-year Report
6th Jul 20237:00 amRNSPlacing and Notice of GM
6th Jul 20237:00 amRNSTrading Statement
4th Jul 20237:00 amRNSBlock listing Interim Review
10th May 202311:31 amRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.